Sodium Succinate Hexahydrate
6106-21-4O.O.O.O.O.O.O=C([O-])CCC(=O)[O-].[Na+].[Na+]ZBTUYCUNQBRXOR-UHFFFAOYSA-LSodium succinate hexahydrate is a hydrate that is the hexahydrate form of sodium succinate. It is used as an ingredient of topical preparations for the treatment of cataract. It has a role as a nutraceutical. It contains a sodium succinate (anhydrous).
안전 정보는 참고용이며, 공급업체의 물질안전보건자료(SDS), 관련 법규 및 전문가 평가를 대체하지 않습니다.
This chemical does not meet GHS hazard criteria for 35.9% (37 of 103) of reports.
Warning
H315 (64.1%): Causes skin irritation [Warning Skin corrosion/irritation]
P261, P264, P264+P265, P271, P280, P302+P352, P304+P340, P305+P351+P338, P319, P321, P332+P317, P337+P317, P362+P364, P403+P233, P405, and P501 (click each P-code to see the statement)
Aggregated GHS information provided per 103 reports by companies from 5 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.
Chemical: Butanedioic acid, disodium salt, hexahydrate
Sodium succinate: Does not have an individual approval but may be used under an appropriate group standard
25 [mg/m3]
270 [mg/m3]
1600 [mg/m3]
용도Disodium Succinate Hexahydrate in conjunction with Melatonin reduced liver mitochondrial dysfunction in rat with diabetes mellitus.
정의ChEBI: A hydrate that is the hexahydrate form of sodium succinate. It is used as an ingredient of topical preparations for the treatment of cataract.
6106-21-4DTXSID70209942CHEBI:63686white crystalline powder